齊心集團(002301.SZ):子公司取得醫療器械註冊證和醫療器械生產許可證
格隆匯 6 月 29日丨齊心集團(002301.SZ)公佈,公司子公司齊心商用設備(深圳)有限公司(“齊心商用設備”)於近日收到廣東省藥品監督管理局頒發的醫療器械註冊證和醫療器械生產許可證。
公司主營業務是B2B辦公物資服務和雲視頻辦公業務。B2B辦公物資業務在疫情期間,防疫用品實際需求加大,公司積極瞭解客户需求,加大產品供應服務。目前子公司齊心商用設備已取得醫療器械註冊證以及醫療器械生產許可證,有利於公司防疫防護物資業務發展。
公司B2B辦公物資業務通過持續疊加商品品類與服務,為客户提供多場景辦公整體解決方案,公司業務成長是多個集成品類的綜合貢獻所致。一次性使用醫用口罩的生產銷售有助於豐富提供給國內央企、政府、金融、軍工等客户和海外客户的防疫防護產品品類,提升服務水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.